Eswatini vs Italy: Access to anti-retroviral drugs, male
Eswatini
84.0%
in 2024
Italy
85.0%
in 2023
Eswatini rank
36th
Italy rank
34th
Access to anti-retroviral drugs, male over time
- Eswatini
- Italy
How they compare
Italy currently reports 85.0% against 84.0% in Eswatini, a difference of 1.0%.
Across all 24 years both countries report, Italy has been ahead every year.
Eswatini ranks 36th and Italy ranks 34th of 141 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 49.0% | 42.3% | Italy |
| 2010s | 48.4% | 74.0% | 25.6% | Italy |
| 2020s | 77.5% | 85.8% | 8.2% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Eswatini or Italy?
- Italy, at 85.0% against 84.0% in Eswatini as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Eswatini and Italy?
- 1.0%, with Italy ahead.
- How many years of comparable data are there for Eswatini and Italy?
- 24 years are reported by both, from 2000 to 2023.
- How do Eswatini and Italy rank globally for access to anti-retroviral drugs, male?
- Eswatini ranks 36th and Italy ranks 34th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.